methanesulfonic acid has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyoshi, T; Honda, M; Inoue, H; Matsuoka, H; Takaki, R; Ueo, H | 1 |
| Bastian, P; Becker, KG; Brenerman, B; Bunz, F; Illuzzi, JL; McKinnon, PJ; McNeill, DR; Russell, HR; Wersto, R; Wilson, DM | 1 |
2 other study(ies) available for methanesulfonic acid and tamoxifen
| Article | Year |
|---|---|
Chemopreventive effects of tamoxifen in ethyl methanesulphonate-induced rat mammary carcinogenesis.
Topics: Animals; Female; Mammary Neoplasms, Experimental; Mesylates; Models, Biological; Rats; Rats, Wistar; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Time Factors | 1993 |
Tumor-associated APE1 variant exhibits reduced complementation efficiency but does not promote cancer cell phenotypes.
Topics: Animals; Cell Cycle; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; DNA Damage; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Fibroblasts; Gene Knockout Techniques; Genetic Complementation Test; HCT116 Cells; Humans; Mesylates; Mice, Transgenic; Tamoxifen | 2017 |